ImprimisRx announced that it has agreed to a product supply agreement with EyeCare Services Partners (ESP). ImprimisRx currently provides a limited number of ophthalmic formulations to practices within the ESP group, but this agreement will expand the number of formulations available to new and existing ESP facilities and allow for additional formulations to be added as the ImprimisRx/ESP relationship continues to expand.
Financial terms of the deal were not disclosed.
ESP is a partnership of 30+ ophthalmologic, optometric brands, and ambulatory surgery centers (ASCs) across multiple states, with 90 locations, 12 ASCs, and 200 providers, representing approximately 100,000 ophthalmic procedures in the U.S. annually.
“EyeCare Services Partners has built an impressive network of eye care providers nationwide and we are honored they have entrusted us with the health outcomes of their patients,” John Saharek, President of ImprimisRx, said in a company news release. “ESP is focused on minimizing distractions and disruptions to patient care and greater access to the ImprimisRx portfolio will support that goal, especially as we continue to innovate and build new solutions in different corners of the ophthalmology market.”